[Selection and construction of cell line stably expressing survivin gene in lower level through eukaryotic plasmid

Wen-Xia Wang1, Shan-Zhen Sun, Ying Song

  • 1Department of Periodontology, College of Stomatology, Shandong University. Jinan 250012, Shandong Province, China. wangwx@sdu.edu.cn

Abstract

Insights

Researchers successfully created short hairpin RNA (shRNA) vectors to suppress survivin gene expression in tongue squamous cell carcinoma cells. This significant reduction in survivin at both mRNA and protein levels offers potential for oral cancer gene therapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Therapy

Background:

  • Survivin is a key protein overexpressed in many cancers, including oral squamous cell carcinoma.
  • Targeting survivin offers a potential therapeutic strategy for oral cancer.

Purpose of the Study:

  • To construct short hairpin RNA (shRNA) interference expression plasmid vectors targeting the survivin gene.
  • To transfect Tca8113 tongue squamous cell carcinoma cells with these vectors.
  • To select and validate cell lines with significantly suppressed survivin expression.

Main Methods:

  • Designed and synthesized survivin-specific oligonucleotide sequences.
  • Cloned sequences into the pSilencer-2.1U6-neo plasmid, creating PS1 and PS2 vectors.
  • Transfected Tca8113 cells using lipofectamine 2000 and selected stable clones with G418.
  • Assessed survivin expression via real-time quantitative PCR and Western blotting.

Main Results:

  • Successfully constructed PS1 and PS2 shRNA vectors and obtained stable transfected cell clones.
  • Significantly suppressed survivin mRNA levels in cells transfected with both PS1 and PS2 (P<0.05).
  • Significantly suppressed survivin protein levels in cells transfected with PS2 (P<0.01).

Conclusions:

  • Successfully developed shRNA expression vectors for survivin gene suppression.
  • Established Tca8113 cell lines with stably reduced survivin expression.
  • These cell lines provide a valuable model for further research into oral squamous cell carcinoma gene therapy.

Related Concept Videos